FDA product code MSV: System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)
MSV is the FDA product code for system,test,antibodies,b2 - glycoprotein i (b2 - gpi). It is a Class II device, regulated under 21 CFR 866.5660 and reviewed by the Immunology panel. FDA has cleared 46 510(k) submissions under MSV, 1 in the last five years, from 18 different applicants. The average 510(k) review took 133 days (median 81); 410 days on average over the last three years. FDA has posted 1 recall for MSV devices.
Classification
| Field | Value |
|---|---|
| Device name | System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) |
| Device class | Class II |
| Regulation | 21 CFR 866.5660 |
| Review panel | IM — Immunology |
| Medical specialty | Immunology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for MSV
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 259 |
| 2018 | 1 | 38 |
| 2026 | 1 | 410 |
Compare with all 510(k) review times · Search every MSV clearance
Top MSV applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Corgenix, Inc. | 8 | 2008-04-04 |
| Inova Diagnostics, Inc. | 7 | 2026-02-06 |
| Pharmacia Deutschland GmbH | 4 | 2004-05-11 |
| The Binding Site, Ltd. | 4 | 2000-05-05 |
| Immco Diagnostics, Inc. | 3 | 2017-06-19 |
13 more applicants have MSV clearances. See the full list in Caduvo.
Most recent MSV clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K243979 | Inova Diagnostics, Inc. | Aptiva APS IgA Reagent | 2026-02-06 | 410 |
| K181329 | Phadia AB | EliA B2-Glycoprotein I IgA Immunoassay, EliA Cardiolipin IgA Immunoassay | 2018-06-25 | 38 |
| K162788 | Immco Diagnostics, Inc. | ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enhanced B2GP1 IgA/IgG/IgM Antibody ELISA | 2017-06-19 | 259 |
| K152875 | Inova Diagnostics, Inc. | QUANTA Flash B2GP1-Domain1, QUANTA Flash B2GP1-Domain1 Controls, HemosIL AcuStar Anti-B2GPI Domain 1, HemosIL AcuStar Anti-B2GPI Domain 1 Controls | 2015-12-21 | 82 |
| K141274 | Inova Diagnostics, Inc. | QUANTA FLASH ¿2GP1-DOMAIN1; CONTROLS, HEMOSIL ACUSTAR ANTI-¿2GPI DOMAIN1; CONTROLS. | 2015-02-13 | 273 |
Recalls for MSV devices
1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2004-10-26.
Frequently asked questions
What is FDA product code MSV?
MSV is the FDA product code for system,test,antibodies,b2 - glycoprotein i (b2 - gpi). It is a Class II device, regulated under 21 CFR 866.5660 and reviewed by the Immunology panel.
What device class is MSV?
Class II, regulation 21 CFR 866.5660. Typical premarket route: 510(k).
How long does a 510(k) take for product code MSV?
Across 46 cleared submissions the average was 133 days from receipt to decision (median 81).
Which companies have the most MSV clearances?
Corgenix, Inc. (8); Inova Diagnostics, Inc. (7); Pharmacia Deutschland GmbH (4); The Binding Site, Ltd. (4); Immco Diagnostics, Inc. (3).
Have MSV devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2004-10-26.
Next steps
- Run an FDA pathway report with predicate devices for product code MSV
- Run a recall and safety report across every MSV manufacturer
- Watch product code MSV for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times